CRMEX
Price
$7.59
Change
-$0.06 (-0.78%)
Updated
Sep 20 closing price
VMCIX
Price
$71.53
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

CRMEX vs VMCIX

Header iconCRMEX vs VMCIX Comparison
Open Charts CRMEX vs VMCIXBanner chart's image
CRM All Cap Value I
Price$7.59
Change-$0.06 (-0.78%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Institutional
Price$71.53
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CRMEX vs VMCIX Comparison Chart
Loading...
VS
CRMEX vs. VMCIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMEX is a Buy and VMCIX is a Buy.

FUNDAMENTALS
Fundamentals
VMCIX has more cash in the bank: 172B vs. CRMEX (25.1M). VMCIX pays higher dividends than CRMEX: VMCIX (1.50) vs CRMEX (0.11). CRMEX was incepted earlier than VMCIX: CRMEX (18 years) vs VMCIX (26 years). CRMEX is a more actively managed with annual turnover of: 51.00 vs. VMCIX (13.00). CRMEX has a lower initial minimum investment than VMCIX: CRMEX (2500) vs VMCIX (5000000). VMCIX (25.16) and CRMEX (23.97) have marching annual gain over last year. VMCIX return over 5 years is better than : 56.92 vs. CRMEX (10.42).
CRMEXVMCIXCRMEX / VMCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years26 years-
Gain YTD15.52512.579123%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets25.1M172B0%
Annual Yield % from dividends0.111.507%
Returns for 1 year23.9725.1695%
Returns for 3 years-9.379.84-95%
Returns for 5 years10.4256.9218%
Returns for 10 years-38.85128.67-30%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEON0.690.02
+3.00%
AEON Biopharma
VRT94.542.48
+2.69%
Vertiv Holdings Co
ELVN23.190.12
+0.52%
Enliven Therapeutics
BOX32.990.15
+0.46%
BOX
QURE5.36-0.32
-5.56%
uniQure NV